Copyright Reports & Markets. All rights reserved.

Lutetium-177 (Lu-177) Market and Pipeline Analysis - Forecast to 2026

Buy now

REPORT DESCRIPTION INTRODUCTION

    EXECUTIVE SUMMARY

      MARKET DYNAMICS (DROT)

        SUPPLY CHAIN ANALYSIS

          • Direct

            • Indirect

              DEALS

                • Acquisition

                  • Agreement

                    • Partnership

                      • Collaboration

                        FUNDING SCENARIO

                          MARKET DATA

                            • TAM and Penetration - GEP-NET (Region)

                              • TAM -Prostate Cancer (Region)

                                ASSUMPTIONS

                                  PIPELINE ANALYSIS

                                    • Development Stage

                                      • Indications

                                        • Major Players

                                          • Molecule Type

                                            RIT BASED PIPELINE ANALYSIS

                                              • By Phase

                                                • By Indiacation

                                                  • Clinical trial update on Phase 3 and Phase 2b molecules PRRT BASED PIPELINE ANALYSIS

                                                    • By Phase

                                                      • By Indiacation

                                                        • Clinical trial update on Phase 3

                                                          MAJOR PLAYERS

                                                            • Company Profiles

                                                              • Overview, Pipeline

                                                                MEDIUM FLUX REACTOR AND LOCATION

                                                                  HIGH FLUX REACTOR AND LOCATION

                                                                    SUPPLIERS OF Lu-177

                                                                      • Annual Estimated Production Capacity

                                                                        REFERENCE

                                                                        “Lutetium-177 Global Market Analysis” gives comprehensive insights on the various Lu-177 based drugs being developed for the treatment of GEP-NET, prostate cancer and other diseases. The report covers marketed products details and also drugs that are in various phases of development (Discovery, Preclinical & Clinical). The pipeline focuses on Lu-177 labeled monoclonal antibodies and peptides for various indications that are in clinical trials, FDA and CE approved products (Lutathera).
                                                                        The report covers the patient population, treatment cost, total addressable market and penetration for GEP-NET and Prostate cancer. It covers list of nuclear reactors that have potential to produce Lu-177 both medium and high flux reactor with their locations all over the world. It also focuses on supply chain analysis and market dynamics (DROT) of Lu-177.
                                                                        This report enables Pharmaceutical/Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative commercial opportunities in the Lu-177 global market. The report also provide strategic insights on some of the molecules which will eventually be launched in the next few years.
                                                                        Market analysis
                                                                        In market analysis section, global GEP-NET and Prostate cancer market are indicated along with the Lu-177 treatment eligible patients size, total addressable market (TAM) and demand for Lu-177 isotope are forecasted from 2019 to 2026
                                                                        Lu-177 market dynamics.
                                                                        Lu-177 related deals analysis.
                                                                        Funding scenario in Lu-177 market
                                                                        Market Size and Total addressable market.
                                                                        Pipeline Analysis
                                                                        Pipeline analysis was carried to get deeper insights on various treatment modalities in discovery, preclinical & development section, pipelines from major companies were identified along with current development status & nature of molecule. Pipeline analysis by developmental stage (Discovery to Clinical development)
                                                                        Pipeline analysis by molecule type
                                                                        Monoclonal Antibodies labeled pipeline analysis
                                                                        Peptide labeled pipeline analysis
                                                                        Pipeline analysis by leading players & their molecule analysis
                                                                        Key Players Analysis
                                                                        The key player’s analysis section provides an in-depth understanding of various companies working on Lu-177 and their pipelines with development phase as well as understanding partnering strategies such as deals entered by the company.
                                                                        Global key players overview
                                                                        Global key players Pipeline data (discovery, pre-clinical & clinical development)
                                                                        Global key players deals (collaborations, partnership, licensing agreements, grants, funds)

                                                                        Buy now